Evidence map›Paper›PMID 26617924›Full record

ArticleInternational journal of clinical and experimental pathology2015

A case of gastric cancer with heterogeneous components of EB virus (+)/TP53 (+) and EB virus (-)/TP53 (-).

Ikuo Matsuda, Kazuomi Kan, Sadayuki Doi, Yoshiyuki Motoki, Masayuki Onodera, Seiichi Hirota

Open access · greenAbstract readCase Reports
In one paragraph

Article in International journal of clinical and experimental pathology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.1field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ikuo MatsudaDepartment of Surgical Pathology Hyogo, Japan.
Kazuomi KanDepartment of Surgery, Kawanishi City Hospital Hyogo, Japan.
Sadayuki DoiDepartment of Surgery, Kawanishi City Hospital Hyogo, Japan.
Yoshiyuki MotokiDepartment of Surgery, Kawanishi City Hospital Hyogo, Japan.
Masayuki OnoderaDepartment of Pathology, Kawanishi City Hospital Hyogo, Japan.
Seiichi HirotaDepartment of Surgical Pathology Hyogo, Japan.
Toyo Institute of Food Technology · JPHyogo Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epstein-Barr virus (EBV)-associated gastric adenocarcinoma is a histological subtype of gastric adenocarcinoma, in which all of the carcinoma cells are basically positive for EBV-encoded small RNA (EBER) by in situ hybridization. Although its typical histology has some overlap with gastric carcinoma with lymphoid stroma, absence of massive lymphoid infiltrate is sometimes observed either in whole or in part. EBV-associated adenocarcinoma is one of the four representative molecular pathological subtypes recently identified by comprehensive genomic analysis of gastric adenocarcinomas. According to the analysis, typical EBV-associated gastric adenocarcinoma constitutes an independent molecular pathological subgroup, which is mutually exclusive to TP53-mutated adenocarcinoma with chromosomal instability, another molecular pathological subtype in gastric adenocarcinomas. Here, we report a rare case of gastric cancer heterogeneously composed of EBER (+)/TP53 (+) and EBER (-)/TP53 (-) portions. The EBER (+)/TP53 (+) component with massive lymphoid infiltrate surrounded the EBER (-)/TP53 (-) component showing well to moderately differentiated tubular adenocarcinoma. Although collision of two independent gastric cancers could be the simplest and most possible explanation for this situation, we discussed another possibility. In the case of gastric collision tumors, concurrent development of EBER (+) gastric adenocarcinomas and EBER (-) gastric adenocarcinomas in a single stomach is a rare incident. Since presence of the EBER (+)/TP53 (+) tumor component is atypical in itself, we also discussed the mechanism of development of the clone.

Indexed as

Adaptor Proteins, Signal TransducingAdenocarcinomaAgedBiomarkers, TumorBiopsyCell DifferentiationGastrectomyHerpesvirus 4, HumanHumansImmunohistochemistryMaleMutL Protein Homolog 1Nuclear ProteinsRNA, ViralStomach NeoplasmsTumor Suppressor Protein p53Adaptor Proteins, Signal TransducingBiomarkers, TumorMLH1 protein, humanMutL Protein Homolog 1Nuclear ProteinsRNA, ViralTP53 protein, humanTumor Suppressor Protein p53adenocarcinoma with lymphoid stromacollision tumorEpstein-Barr virusGastric adenocarcinomaTP53

Identifiers

PMID26617924
PMCPMC4637740
OpenAlexW2182594320

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.